Giving Parkinson's patients their normal life back

Sen is an aftercare solution to monitor bio-signals and symptoms for Parkinson’s patients implanted with deep brain simulation (DBS) therapy devices.
Sen’s innovative blend of wearable sensing and charging capabilities with app-based support system delivers continuous monitoring of motor and non-motor symptoms, providing a solution that fits the patient’s lifestyle and clinician need
s.

Parkinson's disease is the second most common neurodegenerative disorder, affecting more than 10 million people worldwide. The condition affects motor skills causing shaking, slow movement and stiffness. It can also present non motor symptoms such as depression, and problems with speech, sleep, and memory.
Understanding how it works

Deep brain stimulation (DBS) is a therapy that can relieve motor symptoms, giving patients an improved quality of life. The device is implanted under the skin of the chest and delivers electrical impulses to the brain via electrodes. The implant is programmed and recharged through the skin, and existing solutions for this are cumbersome and limited.
Understanding patient pain points

Tackling the challenges that patients and clinicians face is key to increasing the quality of aftercare and improving patient outcomes.
An aftercare ecosystem

The Sen holistic solution features a wearable sensor and charger, adhesive power coil, wrist strap, a docking matt that doubles as a discreet wallet, and an app-based aftercare support system. The wearable tracks characteristic symptoms like tremor, twitch, and postural stability, while the app monitors non-motor symptoms such as speech, mood and pain levels. Sen collects real-time data to support clinicians with objective assessment of disease progression.

Aesthetically, Sen’s iconic design and precious jewel-like sensor are combined with careful use of colour to highlight interaction points and convey a cohesive brand.​​​​​​
Monitoring for multiple symptoms 

Sen monitors multiple motor and non-motor symptoms of Parkinson’s disease. The wearable tracks characteristic freeze, tremor, twitch, walking pattern, postural stability, and sleep pattern symptoms. A companion app is used to monitor non-motor symptoms including speech, writing, mood, and pain levels.

Objective and unbiased assessment

Sen continuously collects real-time characteristics of the patient’s symptoms, and supports clinicians with objective assessment of disease progression. This significantly improves upon the traditional scoring tools used today by eliminating patient cognitive bias during clinical assessment and increases the efficiency of hospital visits. 
Continuous monitoring also reduces the time needed for tuning a new DBS implant.
Charging anytime, anywhere 

Sen gives patients freedom to enjoy every day activities by providing flexible and discreet sensing and battery charging. The portable docking mat recharges the implant charger and stores the system, and can be folded to a wallet size.
Sen can be comfortably worn under clothes for charging and monitoring the neurostimulator implant, on the wrist for monitoring only, or carried inside a flexible wallet so the system is available anytime, anywhere. 
​​​​​​​
Patients feel reassured and empowered with Sen
 
Sen empowers patients to worry less during a complex and emotional time in their lives.
Using the companion app they can check the active performance of their implant, configure stimulation settings, and monitor sensor data. The app also captures information about past episodes and symptoms, relieving the burden of manually logging or remembering these events for discussion with their clinician later.  
Find out more about our winning Red Dot Award.
This content was originally posted on Cambridge Consultants' website. Cambridge Consultants develops breakthrough products, creates and licenses intellectual property and provides business consultancy in technology critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies.
Sen
Published:

Sen

Sen is an aftercare solution to monitor bio-signals and symptoms for Parkinson’s patients implanted with deep brain simulation (DBS) therapy devi Read More

Published: